期刊文献+

rAd/MDC-VP1初免pcDNA3/MDC-VP1加强策略抗CVB3的免疫效果研究 被引量:3

Study on combined immunization of rAd/MDC-VP1 and pcDNA3/MDC-VP1 against Coxsackievirus B3 challenge in mice
下载PDF
导出
摘要 目的:应用柯萨奇病毒B3(CVB3)腺病毒载体疫苗rAd/MDC-VP1初免,核酸疫苗pcDNA3/MDC-VP1加强免疫的策略免疫小鼠,观察其免疫效果。方法:BALB/c小鼠随机分为A~D 4组,分别肌肉注射PBS、rAd/MDC-VP1、pcD-NA3/MDC-VP1、rAd/MDC-VP1+pcDNA3/MDC-VP1,用ELISA和微量中和试验法分别检测CVB3 VP1特异性IgG和中和抗体滴度,CCK-8法检测脾淋巴细胞增殖活性和特异性CTL杀伤活性;用致死量的CVB3攻击小鼠后,检测小鼠血中病毒滴度并观察动物的存活情况。结果:D组CVB3 IgG、非特异性淋巴细胞增殖活性及特异性CTL杀伤活性明显高于其他各组(P<0.05);CVB3攻击后,D组小鼠血中病毒滴度较其他各组显著降低,生存率为41.67%,明显高于其他各组(P<0.05)。结论:rAd/MDC-VP1初免pcDNA3/MDC-VP1加强的免疫策略能显著提高小鼠细胞和体液免疫水平,提高致死量病毒攻击后的保护率。 AIM: To immunize the mice using the rAd/MDC-VP1 prime-pcDNA3/MDC-VP1 boost strategy and observe its immunological effect against Coxsackievirus B3(CVB3).METHODS: BALB/c mice were randomly divided into four groups: PBS group,rAd/MDC-VP1 group,pcDNA3/MDC-VP1 group and rAd/MDC-VP1 prime-pcDNA3/MDC-VP1 boost group.Mice in each group were immunized intramuscularly.The titers of serum IgG and neutralizing antibody were tested by ELISA and trace neutralization assays respectively.The Lymphocytes proliferation activity and specific CTL cytotoxic activity were tested by CCK-8 assay.The mice in each group were challenged with lethal dose of CVB3,and the serum virus titer was assayed and the protection efficacy against Coxsackievirus infection was observed.RESULTS: It was observed that the titers of CVB3 VP1 specific IgG and neutralizing antibody,non-specific lymphocytic proliferation activity and specific lymphocytic CTL cytotoxic activity of the rAd/MDC-VP1 prime-pcDNA3/MDC-VP1 boost group were much higher than those of the rest groups(P〈0.05),what's more,after CVB3 challenged,the serum virus titer of this group was lower and the protection rate(41.67%) was higher(P〈0.05).CONCLUSION: Both the cellular and humoral immune responses in mice could be significantly enhanced by the rAd/MDC-VP1 prime-pcDNA3/MDC-VP1 boost strategy and the protection rate after challenged by lethal dose of virus could be increased.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第3期228-231,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 河北省医学科学研究重点课题(20090049 08265) 河北省科技支撑计划(072761896)
关键词 柯萨奇病毒B3 初免-加强免疫策略 小鼠 Coxsackievirus B3 prime-boost immunization strategy mice
  • 相关文献

参考文献10

  • 1Henke A,Zell R,Stelzner A.DNA vaccine-mediated immune respon-ses in Coxsackie virus B3-infected mice[J].Antiviral Res,2001,49(1):49-54.
  • 2韩小艳,赵娜,高志云,揣侠,羡鲜,蓝佳明,张永红,王永祥.接头长度对MDC与CVB3VP1融合基因疫苗免疫效果的影响[J].中华微生物学和免疫学杂志,2007,27(12):1145-1149. 被引量:9
  • 3闫立景,高志云,蓝佳明,揣侠,李剑,金玉怀,谢立新,王永祥.CVB3腺病毒载体疫苗Ad/MDC-VP1的构建及免疫效果研究[J].中国免疫学杂志,2009,25(9):835-838. 被引量:4
  • 4萨母布鲁克J,拉塞尔DW(黄培堂,等译).分子克隆实验指南[M].3版.北京:科学出版社,1998,95(5):2509-2514.
  • 5闫立景,李剑,温婵,李嘉,蓝佳明,揣侠,高志云,张永红,金玉怀,王永祥.CVB3腺病毒载体疫苗Ad/MDC—VP1与DNA疫苗联合应用的免疫效果[J].中华微生物学和免疫学杂志,2009,29(6):533-537. 被引量:6
  • 6Schaniel C,Pardali E,Sallusto F,et al.Activated murine B lympho-cytes and dendritic cells produce a novel CC chemokine which acts se-lectively on activated T cells[J].J Exp Med,1998,188(3):451-463.
  • 7Yamashita U,Kuroda E.Regulation of macrophage-derived chemokine(MDC,CCL22)production[J].Crit Rev Immunol,2002,22(2):105-114.
  • 8He TC,Zhou S,da Costa LT,et al.A simplified system for genera-ting recombinant adenoviruses[J].Proc Natl Acad Sci USA,1998,95(5):2509-2514.
  • 9Li K,Xu W,Guo Q,et al.Differential macrophage polarization inmale and female BALB/c mice infected with coxsackievirus B3 definessusceptibility to viral myocarditis[J].Circ Res,2009,105(4):353-364.
  • 10Lu K,Xu W,Wang C,et al.Galectin-9 administration amelioratesCVB3 induced myocarditis by promoting the proliferation of regulatoryT cells and alternatively activated Th2 cells[J].Clin Immunol,2011,140(1):92-101.

二级参考文献21

  • 1方艳辉,金玉怀,王永祥,于丹军,金士香,谢立新.人IL-2信号肽基因增强柯萨奇病毒B3型VP1 DNA疫苗诱导的中和抗体应答[J].中华微生物学和免疫学杂志,2004,24(3):202-205. 被引量:11
  • 2张爱华,彭夫望,闭兰,张智,王志友,史良如.抗转铁蛋白受体鼠源性单链抗体基因的构建、表达及初步鉴定[J].中国生物制品学杂志,2005,18(2):81-84. 被引量:3
  • 3王晓凌,高志云,耿媛,金玉怀,王永祥.融合基因DNA疫苗pcDNA3/MDC-VP1对柯萨奇病毒B组3型的免疫效果[J].临床心血管病杂志,2006,22(7):397-399. 被引量:8
  • 4Henke A,Wagner E,Whitton JL,et al.Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization.Virol,1998,72(10):8327-8331.
  • 5J萨母布鲁克,DW拉塞尔,黄培堂,译.分子克隆实验指南:3版.北京:科学出版社,1998:26-96.
  • 6He TC,Zhou S,da Costa LT,et al.A simplified system for generating recombinant adenoviruses.Proc Natl Aced Sci USA,1998,95 (5):2509-2514.
  • 7Sullivan NJ,Sanches A,Rollin PE,et al.Development of a preventive vaccine for Ebola virus infection in primates.Nature,2000,408(6812):605-609.
  • 8Wang S,Kennedy JS,West K,et al.Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA primeprotein boost HIV-1 vaccine in healthy human volunteers.Vaccine,2008,26(31):3947-3957.
  • 9Henke A, Zell R, Stelzner A et al. DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice [ J ]. Antiviral Res, 2001;49 ( 1 ) :49-54.
  • 10J.萨母布鲁克,D.W.拉塞尔著.黄培堂等译.分子克隆实验指南[M].第三版.北京:科学出版社,1998:26-96.

共引文献14

同被引文献33

  • 1王晓凌,吴淑慧,高志云,王永祥.靶向基因疫苗pcDNA3/MDC-VP1的构建及免疫效果[J].河北大学学报(自然科学版),2006,26(1):16-20. 被引量:3
  • 2Murphy TF, Respiratory infections caused by nontypeahle Hae mophilus influenzae [J]. Curr Opin Infect Dis, 2003, 16 (2): 129-34.
  • 3Hotomi M. Toqawa A, Kono M, et al. An application of outer membrane protein p6-specific enzyme-linked immunosorbent assay for detection of Haemophilus influenzae in middle ear fluids and nasopharyngeal secretions[J]. PloS One, 2013. 8(8): 71774.
  • 4Geelen TH, Stassen FR, Hoogkamp Korslanje JA, ct al. Anti microbial resistance among respiratory ttaemophilus influenzae isolates from pulmonology services over a six year period[J]. Scand J Infect Dis, 2013, 45 (8): 606-11.
  • 5Michel LV, Snvder J, Schmidt R, et al. Dual orientation of the outer membrane lipoprotein P6 of nontypeable haemophilus in- fluenzae [J]. J Bacterol, 2013, 195(14): 3252-9.
  • 6Zhu B, Xiao D, Zhang H, et al. MALD1-TOF MS distinctly differentiates nontypable Haemophilus in fluenzae from Haemophilus haemolyticus [J]. PIoS One, 2013, 8(2) : 56139.
  • 7Pichichero ME, Kaur R, Casey JR, et al. Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children[J]. Vaccine, 2010, 28(44): 7184-92.
  • 8Demaria TF, Murwin DM, Leake ER. Irnrnunization with outer membrane protein P6 from nontypeable Haernophilus influenzae induces bactericidal antibody and affords protection in the chinehil- ia model of otitis media[J]. Infect Immun, 1996, 64(12) : 5187-192.
  • 9Biragyn A, Belyakov IM, Chow YH, et al. DNA vaccines enco-ding human immunodeficiency virus-1 glyeoprotein 120 fusions with proinflammatory chemoattractants induce systemic and muco sal immune responses[J]. Blood, 2002, 100(4): 1153-9.
  • 10Webster P, Wu S, Gomez G, et al. Distribution of bacterial proteins in biofilms formed by non-typeable Haemophilus influenzae [ J ]. J Histochem Cytochem, 2006, 54(7) : 829 -842.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部